Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-020103
Filing Date
2021-04-22
Accepted
2021-04-22 16:05:41
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pstv-10q_20210331.htm 10-Q 1164748
2 EX-31.1 pstv-ex311_6.htm EX-31.1 16484
3 EX-31.2 pstv-ex312_8.htm EX-31.2 16122
4 EX-32.1 pstv-ex321_7.htm EX-32.1 11677
  Complete submission text file 0001564590-21-020103.txt   4331999

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pstv-20210331.xml EX-101.INS 695701
6 XBRL TAXONOMY EXTENSION SCHEMA pstv-20210331.xsd EX-101.SCH 43869
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pstv-20210331_cal.xml EX-101.CAL 44293
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pstv-20210331_def.xml EX-101.DEF 134781
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20210331_lab.xml EX-101.LAB 345171
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20210331_pre.xml EX-101.PRE 272364
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34375 | Film No.: 21844812
SIC: 3841 Surgical & Medical Instruments & Apparatus